While flow cytometry shines by its flexibility, it requires a high level of expertise in antibody panel development, relies on experienced operators and is often challenged by inconsistent and ...

Leading the way with the industry’s largest portfolio of CE-IVD labeled flow cytometry reagents in the market, Beckman Coulter Life Sciences announces that it has received a EU Quality Management ...

• ClearLLab Control Cells - a liquid preparation of stabilized human erythrocytes and leukocytes (lymphocytes monocytes and granulocytes) - the first application-specific IVD control cells for L&L* ...

Flow cytometry is a familiar technique that has evolved to meet the needs of modern drug discovery. With automated, high-throughput systems that perform multiplexed analyses and improved dyes for ...

The Seers of Flow Cytometry Predict Applications from Clinical Diagnostics to Drug Discovery Although flow cytometry is a workhorse technology that has been around for more than 50 years, it still ...

Flow cytometry is a widely-used laser-based technique that can be used to measure and quantify cell size, cell granularity, cellular markers, and intracellular components such as proteins and ...

Beckman Coulter Life Sciences acquired the flow cytometry business of India’s ReaMetrix, in a deal that broadens the buyer’s tool and technology offerings to include reagents designed to simplify ...

Flow Cytometry Market size will surpass USD 11 billion by 2032, driven by advancements in biotechnology and the pharmaceutical industries. For instance, Becton, Dickinson and Company announced a study ...

Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter ...

A new report from analyst company BCC Research predicts that flow cytometry, the laser-based technique used in an increasing number of bio-analysis applications, will grow in importance to become a $6 ...

T cells genetically engineered to express a lab-designed chimeric-antigen receptor, or CAR, offer many patients with blood cancer a new treatment option. But while these T cells may have lifesaving ...